within Pharmacolibrary.Drugs.N_NervousSystem.N02C_AntimigrainePreparations.N02CD07_Atogepant;

model Atogepant
  extends Pharmacolibrary.Drugs.ATC.N.N02CD07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N02CD07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Atogepant is an orally administered, small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist, used for the preventive treatment of migraine in adults. It is FDA-approved and is currently used in clinical practice for migraine prevention.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters observed in healthy adult subjects after single and multiple oral doses.</p><h4>References</h4><ol><li><p>Ankrom, W, et al., &amp; Min, KC (2020). Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants. <i>Journal of clinical pharmacology</i> 60(9) 1157–1165. DOI:<a href=\"https://doi.org/10.1002/jcph.1610\">10.1002/jcph.1610</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32297990/\">https://pubmed.ncbi.nlm.nih.gov/32297990</a></p></li><li><p>Boinpally, R, et al., &amp; Trugman, J (2023). Pharmacokinetics and Safety of Coadministered Atogepant and Topiramate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction Study. <i>Clinical pharmacology in drug development</i> 12(10) 1013–1021. DOI:<a href=\"https://doi.org/10.1002/cpdd.1267\">10.1002/cpdd.1267</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37210713/\">https://pubmed.ncbi.nlm.nih.gov/37210713</a></p></li><li><p>Boinpally, R, et al., &amp; Wangsadipura, V (2024). Pharmacokinetics and Safety of Atogepant Co-administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction Study. <i>Clinical pharmacology in drug development</i> 13(8) 930–937. DOI:<a href=\"https://doi.org/10.1002/cpdd.1407\">10.1002/cpdd.1407</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38702918/\">https://pubmed.ncbi.nlm.nih.gov/38702918</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Atogepant;
